Hereditary Colon Cancer Takes Guts

Hereditary Colorectal Cancer Research

Highlights from 2013 - 2014

 

ON-DEMAND available after live event

 

ALL Webinars are available

ON-DEMAND

We would like to thank 

Cancer Prevention Pharmaceuticals

for their generous grant support of this educational activity.

The face of hereditary colon cancer is ever evolving largely due to the remarkable research taking place around the world. Studies are currently underway to increase our knowledge on subjects ranging from chemoprevention, to barriers and psychosocial effects of genetic testing, to genotype of various polyposis conditions, to minimally invasive screening techniques. All of this work gives way to better screening and treatment protocol and translates to a better quality of life and longer life expectancy for HCCS patients. Physicians who stay abreast of these research results are better prepared to deliver a high standard of care to their patients.

 

The “Hereditary Colorectal Cancer Research Highlights from 2013 - 2014” webinar will highlight the most impactful advances in research in the hereditary colon cancer community. Topics will range from advances in screening techniques, to genetic testing, to chemoprevention. We will specifically cover:

 

• Advances in genetic testing

• Chemoprevention clinical trials

• Psychosocial effect of clinical diagnoses, genetic testing, and living with an HCCS

• Minimizing the invasive nature of screening techniques

• Ethnic, cultural, or societal impediments to screening and treatment!

 

 

Target Audience

 

Clinicians, including primary care physicians and gastroenterologists, physician assistants, and certified gastroenterology registered nurses interested in enhancing their knowledge of polyposis conditions; colorectal surgeons interested in broadening their understanding of polyposis conditions and how they relate to bowel diversions; basic and translational researchers and fellows in the fields of gastroenterology and gastrointestinal oncology; genetic counselors who provide care to patients with polyposis conditions or are interested in expanding their scope of care to genetic bowel cancers.

 

 

Course Presenters

 

• Deb Neklason, PhD - University of Utah Huntsman Cancer Institute

• Michael Hall, MD, MS - Fox Chase Cancer Center

 

 

Learning Outcomes

 

At the conclusion of this webinar, participants will:

 

• Have reviewed recent hereditary colorectal cancer research highlights.

• Recognize the potential clinical implications of recent research advances.

• Be able to relate research advances to current research directions.

 

 

Registration Information

 

6 Part Webinar Series: $40*

 

 

CEU Information

 

NSGC CREDIT:

The National Society of Genetic Counselors (NSGC) has authorized the Hereditary Colon Cancer Foundation to offer up to 0.6 CEUs or 6.0 contact hours (Category 1) for Preparing to Treat Polyposis Conditions. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification. 

 

     *At the time of registration, a one time $25 fee will be added for the individual's application         to the NSGC for CEUs. 

 

 

Refund Policy

 

Registration fees cover the cost of CEUs, production and promotion of the webinar series. Proceeds benefit the Hereditary Colon Cancer Foundation. If you would like to receive a refund, please email 24 hours prior to the first webinar(s) start time. Refunds will exclude a 10% processing fee.